Activin Induces X-zone Apoptosis That Inhibits Luteinizing Hormone-dependent Adrenocortical Tumor Formation in Inhibin-deficient Mice

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2003 May 16

PMID 12748296

Citations 28

Authors

Felix Beuschlein

Brendan D Looyenga

Stephanie E Bleasdale

Chris Mutch

David L Bavers

Albert F Parlow

John H Nilson

Gary D Hammer

Affiliations

Soon will be listed here.

Abstract

Inhibin and activin are members of the transforming growth factor beta (TGF-beta) family of ligands produced and secreted primarily by the gonads and adrenals. Inhibin-null (INH(-/-)) mice develop gonadal tumors and-when gonadectomized-adrenocortical carcinoma. The mechanisms leading to adrenal tumorigenesis have been proposed to involve the lack of a gonadal factor and/or a compensatory increase in gonadotropins. In order to achieve elevation of gonadotropins without the concomitant loss of a gonadal hormone, we crossed INH(-/-) mice with a transgenic mouse strain that has chronically elevated luteinizing hormone (LH) levels (LH-CTP). Compound INH(-/-)-LH-CTP mice die within 6 weeks of age from severe cancer cachexia induced by large, activin-secreting ovarian tumors. Unexpectedly, INH(-/-)-LH-CTP mice not only fail to develop adrenal tumors but have smaller adrenals, with a regressed x zone, indicating that elevated LH levels are not sufficient to induce adrenal tumor formation. However, following gonadectomy, INH(-/-)-LH-CTP mice develop large, sex steroid-producing adrenal tumors that arise from the x zone, indicating a growth-promoting effect of high levels of LH on the adrenal cortex in the absence of ovarian tumors. In addition, in vivo and in vitro data indicate that activin induces apoptosis specifically in the adrenal x zone. The restricted expression of activin receptor subunits and Smad2 in cells of the adrenal x zone, together with the elevated activin levels in INH(-/-)-LH-CTP mice, supports the conclusion that activin inhibits adrenal tumor growth by inducing x-zone regression.

Citing Articles

Current insight into the transient X-zone in the adrenal gland cortex.

Kang Y, Laprocina K, Zheng H, Huang C Vitam Horm. 2024; 124:297-339.

PMID: 38408801 PMC: 11023618. DOI: 10.1016/bs.vh.2023.05.003.

Adrenal cortex renewal in health and disease.

Lyraki R, Schedl A Nat Rev Endocrinol. 2021; 17(7):421-434.

PMID: 34011989 DOI: 10.1038/s41574-021-00491-4.

Construction of a risk signature for adrenocortical carcinoma using immune-related genes.

Fu Y, Sun S, Bi J, Kong C Transl Androl Urol. 2020; 9(5):1920-1930.

PMID: 33209656 PMC: 7658150. DOI: 10.21037/tau-20-485.

Androgen receptor signalling in the male adrenal facilitates X-zone regression, cell turnover and protects against adrenal degeneration during ageing.

Gannon A, OHara L, Mason J, Jorgensen A, Frederiksen H, Milne L Sci Rep. 2019; 9(1):10457.

PMID: 31320667 PMC: 6639311. DOI: 10.1038/s41598-019-46049-3.

The transient cortical zone in the adrenal gland: the mystery of the adrenal X-zone.

Huang C, Kang Y J Endocrinol. 2019; 241(1):R51-R63.

PMID: 30817316 PMC: 6675673. DOI: 10.1530/JOE-18-0632.

References

Hirokawa N, Ishikawa H . Electron microscopic observations on postnatal development of the X zone in mouse adrenal cortex. Z Anat Entwicklungsgesch. 1974; 144(1):85-100. DOI: 10.1007/BF00518635. View

Kumar T, Wang Y, Matzuk M . Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice. Endocrinology. 1996; 137(10):4210-6. DOI: 10.1210/endo.137.10.8828479. View

Roberts V, Barth S . Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology. 1994; 134(2):914-23. DOI: 10.1210/endo.134.2.8299586. View

Uchida K, NAGATAKE M, Osada H, Yatabe Y, Kondo M, Mitsudomi T . Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res. 1996; 56(24):5583-5. View

McBride J, Favara B, Steele A, Brown S, Steele P . Congenital hepatoblastoma and Beckwith-Wiedemann syndrome: a case study including DNA ploidy profiles of tumor and adrenal cytomegaly. Pediatr Pathol. 1991; 11(1):131-42. DOI: 10.3109/15513819109064749. View

Cipriano S, Chen L, Burns K, Koff A, Matzuk M . Inhibin and p27 interact to regulate gonadal tumorigenesis. Mol Endocrinol. 2001; 15(6):985-96. DOI: 10.1210/mend.15.6.0650. View

Matzuk M, Finegold M, Mather J, Krummen L, Lu H, Bradley A . Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A. 1994; 91(19):8817-21. PMC: 44697. DOI: 10.1073/pnas.91.19.8817. View

Muscatelli F, Strom T, Walker A, Zanaria E, Recan D, Meindl A . Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature. 1994; 372(6507):672-6. DOI: 10.1038/372672a0. View

Matzuk M, Kumar T, Vassalli A, Bickenbach J, Roop D, Jaenisch R . Functional analysis of activins during mammalian development. Nature. 1995; 374(6520):354-6. DOI: 10.1038/374354a0. View

10.

Kanamaru C, Yasuda H, Fujita T . Involvement of Smad proteins in TGF-beta and activin A-induced apoptosis and growth inhibition of liver cells. Hepatol Res. 2002; 23(3):211-219. DOI: 10.1016/s1386-6346(01)00175-9. View

11.

Pabon J, Li X, Lei Z, Sanfilippo J, YUSSMAN M, Rao C . Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab. 1996; 81(6):2397-400. DOI: 10.1210/jcem.81.6.8964884. View

12.

Chen Y, Lui H, Lin S, Lee J, Ying S . Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood). 2002; 227(2):75-87. DOI: 10.1177/153537020222700201. View

13.

Ling N, Ying S, Ueno N, Shimasaki S, Esch F, Hotta M . Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature. 1986; 321(6072):779-82. DOI: 10.1038/321779a0. View

14.

Keeney D, JENKINS C, Waterman M . Developmentally regulated expression of adrenal 17 alpha-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology. 1995; 136(11):4872-9. DOI: 10.1210/endo.136.11.7588219. View

15.

Hsu S, Lai R, Nanuel D, Hsueh A . Different 5'-flanking regions of the inhibin-alpha gene target transgenes to the gonad and adrenal in an age-dependent manner in transgenic mice. Endocrinology. 1995; 136(12):5577-86. DOI: 10.1210/endo.136.12.7588311. View

16.

Shire J . Degeneration of the adrenal X-zone in Tfm mice with inherited insensitivity to androgens. J Endocrinol. 1976; 71(3):445-6. DOI: 10.1677/joe.0.0710445. View

17.

Risma K, Clay C, Nett T, Wagner T, Yun J, Nilson J . Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci U S A. 1995; 92(5):1322-6. PMC: 42511. DOI: 10.1073/pnas.92.5.1322. View

18.

Malkin D, Li F, Strong L, Fraumeni Jr J, Nelson C, Kim D . Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990; 250(4985):1233-8. DOI: 10.1126/science.1978757. View

19.

Smith C, Mackay S . Morphological development and fate of the mouse mesonephros. J Anat. 1991; 174:171-84. PMC: 1256053. View

20.

LIPSETT M, Hertz R, ROSS G . CLINICAL AND PATHOPHYSIOLOGIC ASPECTS OF ADRENOCORTICAL CARCINOMA. Am J Med. 1963; 35:374-83. DOI: 10.1016/0002-9343(63)90179-7. View